XML 85 R74.htm IDEA: XBRL DOCUMENT v3.5.0.2
(LOSS) EARNINGS PER SHARE - Schedule of (Loss) Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Earnings Per Share [Abstract]        
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc. $ (1,218.4) $ 49.5 $ (1,894.4) $ 94.2
Basic weighted-average number of common shares outstanding (in shares) 349.5 344.9 346.5 340.8
Diluted effect of stock options, RSUs and other (in shares) 0.0 6.1 0.0 6.4
Diluted weighted-average number of common shares outstanding (in shares) 349.5 351.0 346.5 347.2
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:        
Basic (in usd per share) $ (3.49) $ 0.14 $ (5.47) $ 0.28
Diluted (in usd per share) $ (3.49) $ 0.14 $ (5.47) $ 0.27